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Semicarbazide sensitive amine oxidase (SSAO) metabolizes oxidative deamination of primary aromatic and aliphatic amines. It is selectively
expressed in vascular cells of blood vessels, but it is also circulating in blood plasma. SSAO activity in plasma is increased in some diseases
associated with vascular complications and its catalytic products may cause tissue damage. We examined the effect of the oxidation of the SSAO
substrate, methylamine, on cultured smooth muscle cells. Cell incubation with methylamine plus soluble SSAO, contained in bovine serum,
resulted toxic to rat aorta A7r5 and human aortic smooth muscle cells, as measured by MTT reduction. This effect was completely reverted by
specific SSAO inhibitors, indicating that the toxicity was mediated by the end products generated. Moreover, SSAO-mediated deamination of
methylamine induced apoptosis in A7r5 cells, detected by chromatin condensation, Caspase-3 activation, PARP cleavage and cytochrome c
release to cytosol. Formaldehyde, rather than H2O2, resulted to be a strong apoptotic inducer to A7r5 cells. Taken together, the results suggest that
increased plasma SSAO activity in pathological conditions, could contribute to apoptosis in smooth muscle cells, leading to vascular tissue
damage.
© 2006 Elsevier B.V. All rights reserved.Keywords: Semicarbazide Sensitive Amine Oxidase; Methylamine; Formaldehyde; Hydrogen peroxide; Apoptosis; Aortic smooth muscle cell1. Introduction
Semicarbazide Sensitive Amine Oxidase [E.C.1.4.3.6,
oxidoreductase (deaminating) (copper-containing), SSAO]
constitutes a large family of enzymes present in almost all
mammalian species studied. All these enzymes are inhibited by
semicarbazide [1,2]. SSAO catalyses the oxidative deamination
of primary aromatic and aliphatic amines. Its catalytic action
requires oxygen and generates ammonia, hydrogen peroxide
(H2O2) and the corresponding aldehyde. Aminoacetone and
methylamine (MA) are considered the physiological substrates
of SSAO [3] and their oxidation generates the toxic end
products, methylglioxal and formaldehyde, respectively [4].⁎ Corresponding author. Fax: +34 93 5811573.
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doi:10.1016/j.bbamcr.2005.11.017SSAO is associated with cell membranes and it is also present in
blood plasma [2,5]. Membrane-bound SSAO is predominantly
expressed in adipocytes, smooth muscle and endothelial cells
from blood vessels [1,2,6].
The physiological role of SSAO is still far from clear and it is
considered to be a multifunctional enzyme, depending on the
tissue where it is expressed [7]. In adipocytes, SSAO activity
stimulates glucose transport, mimicking the insulin effect
through the H2O2 generated during the catalytic process [8].
In addition, SSAO, also known as vascular adhesion protein-1
(VAP-1) [9], is involved in lymphocytes trafficking [10] and its
expression in endothelial cells is induced during inflammation.
Some authors have proposed that soluble SSAO is derived
from themembrane-bound enzyme [11,12]. Recently, it has been
reported that soluble SSAO is shed from the membrane by a
metalloprotease activity in adipocytes [11]. Furthermore,
transgenic mouse models expressing human VAP-1 in
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the major source of circulating SSAO in mice [12].
Plasma SSAO activity is increased in several pathological
conditions; diabetes type I and II [13], congestive heart failure
[14] and non diabetic morbid obesity [15], and it has also been
implicated in atherosclerosis [16,17]. The products generated by
SSAO, formaldehyde and H2O2, have been considered a
potential risk factor for stress-related angiopathy [18,19].
H2O2, a major reactive oxygen species, is the principal
generator of oxidative stress, which is widely implicated in
several diseases. On the other hand, formaldehyde is a highly
reactive aliphatic aldehyde, which is considered to be a
powerful inflammatory agent [20]. The combined effect of
these products could contribute to vascular degeneration
associated to several disease states. Alzheimer's disease (AD)
patients exhibit significant cerebrovascular pathology, such as
microvascular degeneration affecting smooth muscle cells and
endothelial cells, hyalinosis and fibrosis. In this context, we
have previously reported that membrane-bound SSAO is
overexpressed in the cerebrovascular tissue of AD and
CADASIL (Cerebral Autosomal Dominant Arteriopathy with
Subcortical Infarcts and Leukoencephalopathy) patients, with
the subsequent perturbation of the brain vasculature [21].
Moreover, we have recently reported that soluble SSAO activity
is increased in patients suffering of severe AD [22]. There is a
need to examine if the increase in SSAO activity is correlated to
the vascular damage in this pathology.
Since MA and plasma SSAO levels are increased in certain
diseases [23,24], we examined whether soluble SSAO, through
its catalytic action, induces cell death in cultured smooth muscle
(SMC). As A7r5 cells and HASMC (Human Aortic Smooth
Muscle Cells) do not show SSAO activity or expression, bovine
serum (BS) with high SSAO activity was used as the source of
soluble enzyme. Different amines; MA, tyramine (TYR) and
benzylamine (BZ), were used as SSAO substrates.
2. Methods
2.1. Materials
Dulbecco's modified Eagle's medium, fetal bovine serum (FBS), L-
glutamine, penicillin, streptomycin and trypsin were obtained from Gibco
BRL (Grand Island, NY, USA). Bovine Serum (BS) was from Biosystems
(Barcelona, Spain). Methylamine, tyramine, benzylamine, semicarbazide, H2O2,
formaldehyde, Hoechst 33258 and other chemicals were purchased from Sigma
Aldrich (St. Louis, Mo., USA). MDL72974A ((E)-2-(4-fluorophenethyl)-3-
fluoroallylamine hydrochloride) was a kind gift from Dr. P.H. Yu (University of
Saskatchewan, Saskatchewan, Canada). The primary antibodies used were anti-
cleaved Caspase-3 antibody from Cell Signaling (Beverly, MA, USA), anti-
PARP from Upstate Biotechnology, Inc. (Lake Placid, NY, USA), anti-
cytochrome c from BD Biosciences Pharmingen (San Diego, CA, USA) and
anti-β-actin from Sigma Aldrich (St. Louis, Mo., USA). The secondary
antibodies used were goat anti-rabbit IgG Alexa Fluor 594 from Molecular
Probes (Eugene, OR, USA), HRP anti rabbit IgG from BD Biosciences
Pharmingen and HRP anti-mouse IgG from Dako Cytomation (Glostrup,
Denmark).
2.2. SSAO activity determination
SSAO activity was determined radiochemically at 37 °C as previously
described [25] using 100 μM [14C]-benzylamine (3 mCi/mmol, Amersham, UK)as substrate. Samples were preincubated for 30 min at 37 °C with 1 μM L-
deprenyl to inhibit possible platelet MAO B contamination. The reaction was
carried out at 37 °C in a final volume of 225 μl 50mMTris–HCl buffer, pH 9, and
stopped by the addition of 100 μl 2 M citric acid. Radiolabelled products were
extracted into toluene/ethyl acetate (1:1, v/v) containing 0.6% (w/v) 2,5-
diphenyloxazole (PPO) before liquid scintillation counting. Different BS batches
were tested and selected only when SSAO specific activity was 60 pmol/min mg
protein. SSAO activity in cell treatments is expressed as U/ml (1 Unit produces 1
μmol/min of the catalytic product).
SSAO kinetic constants towards benzylamine, methylamine and tyramine
(0.1–10 mM) as substrates were determined using a continuous spectrophoto-
metric method coupled to peroxidase [26]. 4-Aminoantipyrine is oxidized by the
hydrogen peroxide formed during amine oxidation and then condenses with
vanillic acid to give a red quinone imine dye. The absorbance at 498 nm is
proportional to the amount of hydrogen peroxide generated. Product
concentrations were measured using a Cary spectrophotometer and Km and
Vmax values were calculated using the Graph-Pad Prism 3.0 program.
2.3. Cell culture
Human Aortic Smooth Muscle Cells (HASMC) from normal adult thoracic
aortas were obtained from control donor heart transplants. Samples were
provided by Hospital de la Vall d’Hebron, Barcelona, according to the Rules and
Procedures of its Ethics Committee. The smooth muscle cells from aorta were
isolated by the explant method and cultured as described previously [27]. Cells
were used at passages 3–8 and characterized as smooth muscle by morphologic
criteria and expression of smooth muscle -actin. Rat aortic smooth muscle cells
A7r5 were obtained from ATCC. Cells were grown in high glucose (4,500 mg/l)
DMEM supplemented with 10% (v/v) FBS, 2 mM L-glutamine, 1000 U/mL
penicillin, 1000 μg/mL streptomycin. Cells were seeded at 50000 cell/ml and
grown at 37 °C in a humidified atmosphere containing 5% CO2. For
experiments, cells were grown for 2 days and starved with DMEM containing
0.2% (v/v) FBS for H2O2 or formaldehyde treatments. For MA treatments, cells
were replaced with DMEM (0% FBS) containing 5, 10 or 15% (v/v) of Bovine
Serum (BS), which corresponds to 3×10−4, 6×10−4 and 9×10−4 U/ml of SSAO
activity, respectively. SSAO inhibitors, semicarbazide or MDL72974A, were
coincubated with MA in DMEM supplemented with BS.
2.4. Cell viability
Mitochondrial activity was estimated byMTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) reduction assay. After treatments, MTT (0.5
mg/ml) was added to cells and after 90 min incubation at 37 °C the medium was
replaced by dimethyl sulfoxide. The amount of formazan blue formed after MTT
reduction was quantified spectrophotometrically at 560 nm [28].
2.5. Active Caspase-3 immunocytochemistry and detection of
apoptotic nuclei using Hoechst 33258 staining
Analysis of active Caspase-3 was performed on treated A7r5 cells seeded on
coverslips. Cells were fixed with 4% paraformaldehyde for 30 min at room
temperature and washed in PBS containing 0.1% Tween 20. Coverslips were
then incubated with a blocking solution containing 1% (w/v) Bovine Serum
Albumin. Anti-cleaved Caspase-3 diluted 1:100 in blocking buffer was
incubated overnight at 4 °C, washed in PBS/0.1% Tween 20, and thereafter
incubated with the secondary antibody anti-rabbit IgG Alexa Fluor 594 diluted
1:1000 for 1 h. For nuclear staining, coverslips were washed in PBS and
incubated with Hoechst 33258 (1 μg/ml) for 10 min at room temperature in the
dark. Three independent experiments were performed and three fields of each
treatment in duplicate were counted. At least 1000 cells were counted for each
treatment.
2.6. Detection of PARP cleavage and cytochrome c release by Western
Blot analysis
For cleaved PARP detection in total cell lysates, cells were washed in
cold PBS and lysed in a buffer containing 50 mM Tris–HCl pH 6.8, 10%
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detect cytochrome c release, cells were harvested in 250 μl of ice-cold buffer
containing 50 mM Tris–HCl (pH 7.4), 1 mM EDTA, 1 mM dithiothreitol,
complete protease inhibitor, and 250 mM sucrose, after washing once in cold
PBS. Cells were incubated for 30 min on ice and then disrupted by
douncing 10 times with a tight pestle in a 7 ml Weathon douncer. After
centrifugation at 800×g for 10 min at 4 °C, supernatants were centrifuged at
20,000×g for 40 min at 4 °C. The resulting supernatants were saved as
cytosolic extracts. Protein determinations were made using the Bradford
method. Samples were size fractionated by SDS-PAGE and transferred to
nitrocellulose membranes. Membranes were blocked for 1 h with Tris-
buffered saline (TBS), 0.1% Tween 20 and 5% (w/v) defatted powderedFig. 1. MA oxidation by soluble SSAO induces cytotoxicity in A7r5 cells e
different methylamine (MA) and soluble SSAO concentrations for 24 h (B) 1
and (C) 1 mM MA plus 9×10−4 U/ml of soluble SSAO and SSAO inhibit
mean±S.E.M. values of three separate experiments performed in triplicate. ***
Multiple Comparison Test.milk, and incubated overnight with the corresponding antibody diluted
1:1000 in blocking buffer. Membranes were developed using ECL®
detection reagents from Amersham Pharmacia Biotech (Piscataway, NJ,
USA).
2.7. Statistics
Results are given as means±S.E.M. Statistical analysis was done by one-
way ANOVA and further Newman–Keuls Multiple Comparison Test using the
program Graph-Pad Prism 3.0. A P value of less than 0.05 was considered to be
statistically significant.xpressed as MTT reduction percentages. Cells were incubated with (A)
mM MA and different soluble SSAO concentrations for 6, 12 and 24 h,
ors, 1 mM semicarbazide and 10 μM MDL72974A, for 24 h. Data are
Pb0.001 by a one-way ANOVA test and the addition of Newman–Keuls
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3.1. MA oxidation by soluble SSAO induces cytotoxicity in
A7r5 cells
Although the smooth muscle cell line A7r5 showed some
MAO-A activity (100 pmol/min mg protein) determined
radiochemically by serotonin oxidation, cells did not present
MAO-B or SSAO activity assayed towards benzylamine as
substrate. These conditions allowed us to study the soluble
SSAO catalytic action on vascular cells. For this purpose, a
bovine serum (BS) was used as the enzyme source, due to the
large homology (81%) between soluble bovine amine oxidase
and human SSAO [29]. We first studied methylamine (MA)
oxidation by soluble SSAO on A7r5 cell viability, because this
aliphatic amine is considered as a common substrate of bovine
and human plasma SSAO [30].
A7r5 cells were treated with increasing concentrations of
soluble SSAO and MA, and cell viability was measured by the
MTT reduction assay. Soluble SSAO (3×10−4, 6×10−4 and
9×10−4 U/ml) and 1 mM MA did not affect cell viability by
themselves. However, 1 mM MA plus 9×10−4 U/ml of soluble
SSAO induced a 70% decrease of total MTT reduction after 24
h treatment (Fig. 1A). The toxic effect was dose-dependent,
obtaining a significant decrease in MTT reduction with 0.1 mM
MA plus 6×10−4 U/ml or 9×10−4 U/ml of soluble SSAO (20%
and 25% respectively on MTT reduction percentages). On the
other hand, cell viability decrease was time dependent in the
range studied (6, 12 and 24 h) (Fig. 1B). In order to confirm that
cell viability loss was mediated by the SSAO activity contained
in the BS, the experiment was performed using two specific
SSAO inhibitors. Enzymatic activity was completely inhibited
by 1 mM semicarbazide and 10 μM MDL-72974A, but cell
viability was not affected at these concentrations. These SSAO
inhibitors completely reverted the loss of cell viability caused
by 1 mM MA plus 9×10−4 U/ml of soluble SSAO (Fig. 1C).
3.2. Effect of benzylamine and tyramine oxidation by soluble
SSAO on A7r5 cells
Other SSAO substrates, benzylamine (BZ) and tyramine
(TYR), were tested in the same experimental conditions.
Incubation of A7r5 cells with 1 mM TYR and 9×10−4 U/ml
of soluble SSAO resulted in a 90% decrease of total MTT
reduction after 24 h. This effect was almost totally reverted by
the presence of SSAO inhibitors (Fig. 2A). MAO inhibition by
1 μM clorgyline did not affect the cell viability, which ruled out
the involvement of other amine oxidases activity in the process.
In contrast, the non-physiological substrate BZ 1 mM, showed a
slight toxic effect by itself, but no significant changes were
observed in the presence of soluble SSAO (Fig. 2B). Inhibition
of MAO or SSAO activity did not protect the cell death induced
by BZ, demonstrating that they were not involved in the
cytotoxicity. The enzyme kinetic parameters were determined
towards the different SSAO substrates; MA, BZ and TYR. BZ
was the best bovine serum SSAO substrate in terms of Vmax/Km
ratio (Fig 2C), as previously described [30], followed by TYRand MA. In this context, the non cytotoxic effect observed after
BZ metabolism suggests that the aldehyde produced by SSAO,
rather than H2O2 or ammonia, is the main factor responsible for
the reduction in cell viability.
3.3. MA oxidation by SSAO induces apoptosis in A7r5 cells
We then evaluated whether apoptosis would be involved in
such toxic effect. Fig. 3 shows the double staining with Hoechst
33258 and anti-cleaved Caspase-3 antibody. Cleavage of the
executer Caspase-3 into the active form is considered as a
classical apoptotic feature. On the other hand, Hoechst 33258
staining display apoptotic cells with condensed, crescentic-
aggregated, segmented or fragmented nuclei characteristic of
apoptosis. Cell incubations with 1 mM MA or 9×10−4 U/ml of
soluble SSAO separately for 24 h did not show stained positive
cells (Fig. 3D and E). However, co-incubation with 1 mM MA
and 9×10−4 U/ml of soluble SSAO resulted in numerous cells
displaying a strong cytoplasmic red staining for cleaved
Caspase-3 (Fig. 3B). The detailed micrograph shows that
stained positive cells overlap with condensed nuclei stained
with Hoechst 33258 (see Fig. 3B inset). Although 1 mM
semicarbazide had no toxic effect by itself (Fig. 3F), it
significantly diminished the number of cleaved Caspase-3-
positive cells, indicating that the amine oxidase activity
mediated the apoptotic process (Fig. 3C). The high percentage
of active Caspase-3-positive cells (Fig. 3G) indicated that
apoptosis was the main factor responsible for the cell death
observed.
We also evaluated other apoptotic features; Poly (ADP-
ribose) polymerase (PARP) is one of the essential substrates
cleaved by executioner caspases and it is involved in
maintaining DNA stability and repair. Western blot analysis
revealed PARP cleavage only in cells treated with 1 mM MA
plus 9×10−4 U/ml of soluble SSAO for 24 h (Fig. 4A),
confirming the Caspase-3 activation observed. On the other
hand, cytosolic fractions of cells showed a time-dependent
increase in cytochrome c levels (Fig. 4B), as a consequence of
its release from mitochondria to cytosol. Cytochrome c
appeared after 12 h of soluble SSAO and MA co-treatment,
indicating that it could be an early event in the intrinsic
apoptosis pathway, before Caspase-3 activation and PARP
cleavage determined at 24 h.
3.4. Effect of SSAO catalytic products on A7r5 cells
In order to study the mechanism involved in the toxicity
observed, we next analyzed the direct effect of the final products
generated by SSAO catalytic activity: H2O2, ammonia and
different aldehydes (formaldehyde or benzaldehyde, which are
the products of MA or BZ oxidation respectively). Considering
the oxidative deamination stoichiometry (1:1) of primary
amines [30] and our previous assays, which were performed
at 1 mM MA, the products concentration range selected for
treatments was from 0.1 to 1 mM. When cells were incubated in
the presence of ammonia, no toxic effect was observed (Fig.
5A). In contrast, cells incubated with H2O2 for 24 h presented a
Fig. 2. Effect of different SSAO substrates oxidation in A7r5 cells. Cells were incubated for 24 h with (A) 9×10−4 U/ml of soluble SSAO plus 1 mM benzylamine (BZ)
and SSAO inhibitors, 1 mM semicarbazide and 10 μMMDL72974A, or MAO-A inhibitor, 1 μM clorgyline, (B) 9×10−4 U/ml of soluble SSAO plus 1 mM tyramine
(TYR) and 1 mM semicarbazide, 10 μM MDL72974A or 1 μM clorgyline. Data are mean±S.E.M. values of three separate experiments performed in triplicate.
Statistically differences expressed as ***Pb0.001 by a one-way ANOVA test and the addition of Newman–Keuls Multiple Comparison Test compared to control
samples. (C) Kinetic constants of soluble SSAO towards BZ, MA, TYR as substrates (0.1, 0.5, 1, 5, 7.5, 10 mM) determined spectrophotometrically following the
H2O2 generated.
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MTT reduction at 1 mM H2O2 (Fig. 5B). When formaldehyde
was assayed at the same concentration range, the percentage of
MTT reduction decreased drastically at much lower concentra-
tions, compared to H2O2 treatment (Fig. 5C). Formaldehyde 0.5
mM induced almost 100% loss of cell viability. On the otherhand, benzaldehyde treatment did not show changes in cell
viability by itself (Fig 5D), demonstrating that BZ oxidation did
not induce cytotoxicity because of the inert effect of the
aldehyde generated.
We then examined whether the cytotoxic products induced
apoptosis in A7r5 cells. Although it has been widely reported
Fig. 3. MA oxidation by soluble SSAO induces Caspase-3 activation and nuclei condensation in A7r5 cells. Representative immunostaining with anti-cleaved
Caspase-3 antibody and Hoechst 33258 of (A) control, (B) 9×10−4 U/ml of soluble SSAO+1 mM MA, (C) 9×10−4 U/ml of soluble SSAO+1 mM MA+1 mM
semicarbazide (SC), (D) 9×10−4 U/ml of soluble SSAO, (E) 1 mM MA, and (F) 1 mM SC, for 24 h. Scale bar=50 μm in A–E and F and 25 μm in B inset. (G)
Percentages of cleaved Caspase-3-positive cells. Data are mean±S.E.M. values of two separate experiments performed in triplicate.
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including smooth muscle cells [31], it was not known if
formaldehyde was able to induce apoptosis in this cell type. 0.5
mM formaldehyde treatment for 24 h induced a 75% cleaved
Caspase-3 stained cells (Fig. 6A). Hoechst 33258 staining of
positive cells also revealed the characteristic condensed
morphology of apoptotic nuclei. In contrast, when cells were
treated with H2O2 in the same experimental conditions, only
10% of cells were positive for cleaved Caspase-3 cells (Fig.
6B). On the other hand, formaldehyde treatment for 24 h showedFig. 4. MA oxidation by soluble SSAO induces apoptosis in A7r5 cells.
Representative immunoblot of (A) PARP cleavage after 24 h treatment, and (B)
time-dependent (12 and 24 h) cytochrome c release to cytosol. β-Actin is used as
loading control.a clear PARP cleavage at all concentrations studied (Fig. 7A).
Since this is one of the latest events in the apoptosis pathway,
cells treated with H2O2 only showed PARP cleavage at longer
time (42 h) (Fig. 7B).
3.5. MA oxidation by soluble SSAO induces cytotoxicity in
HASMC
To examine whether the toxic effect induced by MA
oxidation was attributable to the cell line, cell viability
experiments were performed on primary cultures of smooth
muscle cells from human aorta (HASMC). When cells were
incubated in the presence of 1 mM MA plus 9×10−4 U/ml
of soluble SSAO, only a 35% decrease of total MTT
reduction was observed at 24 h (Fig. 8), in comparison with
the 75% observed on A7r5 cells. These results indicate that
cells from the primary culture are more resistant to the
toxicity mediated by SSAO metabolic products. SSAO
inhibitors, semicarbazide 1 mM and MDL72974A 10 μM,
had no toxic effect by themselves, but recovered the loss of
cell viability induced by SSAO catalysis. Since these cells
do not present membrane-bound SSAO activity, MA
oxidized by soluble SSAO was again the only factor
responsible for the cell damage.
4. Discussion
Plasma levels of SSAO and its substrate MA are increased in
certain diseases [13,22–24]. Although oxidation of the synthetic
Fig. 5. Catalytic products generated by SSAO activity induce cytotoxicity in A7r5 cells expressed as MTT reduction percentages obtained from the incubation with
different concentrations of (A) H2O2, (B) NH4
+, (C) formaldehyde and, (D) benzaldehyde for 24 h. Data are mean±S.E.M. values of three separate experiments
performed in triplicate.
Fig. 6. SSAO cytotoxic catalytic products (H2O2 and formaldehyde) induce Caspase-3 activation and nuclei condensation on A7r5 cells. Representative
immunostaining with anti-cleaved Caspase-3 antibody and Hoechst 33258 of (A) control, (B) 0.5 mMH2O2 and (C) 0.5 mM formaldehyde, after 24 h treatment. Scale
bar=50 μm. (D) Percentages of cleaved Caspase-3-positive cells. Data are mean±S.E.M. values of two separate experiments performed in triplicate.
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Fig. 8. MA oxidation by soluble SSAO induces cytotoxicity in HASMC
expressed as MTT reduction percentages obtained with the incubation of
9×10−4 U/ml of soluble SSAO plus 1 mM MA and SSAO inhibitors,
semicarbazide and MDL72974A, for 24 h. Data are mean±S.E.M. values of
three separate experiments performed in triplicate. **Pb0.01, *Pb0.05 by a
one-way ANOVA test and the addition of Newman–Keuls Multiple Comparison
Test.
Fig. 7. H2O2 and formaldehyde induce apoptosis on A7r5 cells. Representative
immunoblot of PARP cleavage after formaldehyde treatment for 24 h and H2O2
treatment for 24 and 42 h.
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(SMC) [32,33], these cells are resistant to MA toxicity [34],
probably because of the low basal SSAO activity in cultured
SMC. However, MA was toxic to endothelial cells in the
presence of soluble SSAO [35]. Here we examine the effect of
MA deamination by circulating SSAO on SMC as a potential
risk factor of vascular damage, when the enzyme level is
significantly increased in pathological conditions.
Although SSAO is constitutively expressed in vascular
smooth muscle [2], A7r5 and HASMC do not show SSAO
activity or expression. This could be explained by the difficulty
of maintaining a differentiated contractile phenotype in culture.
It has been widely reported that vascular SMC show plasticity in
vivo and in vitro, which allows them to change phenotype in
response to environmental changes [36]. Moreover, the loss of
SSAO/VAP-1 expression in vascular cells has also been
reported [35,37].
In this study, we show that soluble SSAO plus 1 mM MA
was cytotoxic in A7r5 and HASMC cells. Because our
experimental model is based on cultured cells, we studied an
acute MA treatment for 24 h, using a higher amine
concentration than those previously reported in human plasma
[23]. Although this MA concentration is outside the physio-
logical range, it has been widely used in cell culture studies
[33–35,37]. The cytotoxicity observed was reverted when cells
were preincubated with the specific SSAO inhibitors, semi-
carbazide or MDL 72974A, showing that cell death induction
was due to the SSAO catalytic action, discarding other damage
sources in the BS used. Furthermore, the catalytic products
assayed separately, formaldehyde and H2O2, were cytotoxic,
while ammonia was not. Formaldehyde, generated by MA
oxidation, was much more toxic than H2O2 in the same
experimental conditions, as reported in endothelial cells [35].
However, free radicals can be generated from formaldehyde and
H2O2, which may contribute synergically to oxidative stress
[38] and vascular damage. Only the oxidation of physiological
substrates, MA and TYR, was toxic to A7r5 cells. In contrast,
oxidation of the non-physiological substrate, BZ, by SSAO did
not affect cultured cells. Because SSAO showed the highest
affinity towards BZ, the differences in the cytotoxicity may be
attributed to the specific reactivity and the chemical structure of
the aldehyde generated. This hypothesis was confirmed by thelack of cytotoxicity obtained with benzaldehyde in comparison
with formaldehyde.
Apoptosis of vascular SMC occurs during normal blood
vessel development and maturation, but it has also been
implicated in vascular disease [39]. Biogenic amines appear to
be important for apoptosis triggering through the catalytic
action of mitochondrial monoamine oxidase [40]. However, up
to now, no direct evidence had shown that circulating SSAO
induces apoptosis in SMC. In the present study apoptosis
induced by MA oxidation was observed by chromatin
condensation, Caspase-3 activation and PARP cleavage.
Moreover, the release of mitochondrial cytochrome c to cytosol
suggests that mitochondrial-mediated apoptosis is involved,
probably through the oxidative stress generated by SSAO
catalytic action. However, further studies are needed to
elucidate whether other mechanisms or apoptotic pathways
are also involved.
In pathological conditions, such as neurodegenerative
diseases, stroke, traumatic brain injury, atherosclerosis and
hypertension, oxidative stress contributes to apoptosis. Among
the various factors that can induce oxidative damage, H2O2 plays
a key role because it is generated in nearly all sources of
oxidative stress and can diffuse freely in and out of cells and
tissues [41]. In this study, we show that formaldehyde is a
stronger inducer of apoptosis than H2O2. Formaldehyde can
generate covalent interactions with macromolecular constituents
in biological samples [42], altering cellular structures and
inducing cell death. The ability of formaldehyde to generate
cross-linking with proteins, DNA and other macromolecules,
could explain the alteration of mitochondrial membrane
structures, inducing the opening of the mitochondrial transition
pore, promoting cytochrome c release to the cytosol, caspase
activation and cell death. The apoptotic rate obtained after for-
maldehyde treatment is consistent with reports of the formation
of glucose degradation products, such as methylglyoxal and
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[43].
Transgenic mice models that express full-length human
VAP-1/SSAO in smooth muscle cells [44], endothelial cells or
adipose tissue [12], show an increase in hVAP-1/SSAO in
serum. This increase is dramatically higher when transgenic
animals are treated with experimental diabetes inducers [12].
These results are in agreement with those data previously
reported in human dysfunctions [13].The increase of blood MA
and the resulting blood formaldehyde is potentially harmful
because of the absence of formaldehyde dehydrogenase in
blood plasma [45]. In vivo studies corroborate the toxic
consequences of MA: chronic MA administration to SSAO/
VAP-1 transgenic mice produced vascular complications related
to diabetes pathology [46]. Moreover, there is evidence that
increased SSAO-mediated deamination of MA contributes to
protein deposition, formation of plaques and inflammation [47].
In this concern, transgenic mice overexpressing VAP-1/SSAO
in SMC present pathological changes in the elastic fibers of
aorta, suggesting the contribution of tissue-bound SSAO in the
development of vascular damage [44].
Herein, we report for the first time, at molecular level, that
plasma SSAO, through its catalytic action on the physiological
substrate MA, induces apoptosis in SMC. The formaldehyde
generated by SSAO seems to be the main contributor to cell
death, by altering the mitochondria homeostasis and inducing
apoptosis. However, a synergic effect of formaldehyde and
H2O2 cannot be rule out.
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